Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both

Circulation

Volumn 122, Issue 6, 2010, Pages 597-602

  Pouleur, Anne Catherine ^a   Barkoudah, Ebrahim ^a   Uno, Hajime ^b   Skali, Hicham ^a   Finn, Peter V ^a   Zelenkofske, Steven L ^c   Belenkov, Yuri N ^d   Mareev, Viacheslav ^d   Velazquez, Eric J ^e   Rouleau, Jean L ^f   Maggioni, Aldo P ^g   Køber, Lars ^h   Califf, Robert M ^e   McMurray, John J V ⁱ   Pfeffer, Marc A ^a   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Regado Biosciences   (United States)

^d INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f MONTREAL HEART INSTITUTE   (Canada)

^g ANMCO RESEARCH CENTER   (Italy)

^h Rigshospitalet   (Denmark)

ⁱ WESTERN INFIRMARY   (United Kingdom)

Author keywords

autopsy; death, sudden; heart failure; heart rupture; myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; VALSARTAN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; AUTOPSY; CANCER PATIENT; CAUSE OF DEATH; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CONTRAST; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART RIGHT VENTRICLE FUNCTION; HEART RUPTURE; HUMAN; INFORMATION PROCESSING; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECURRENT DISEASE; STROKE; SUDDEN DEATH;

AGED; AGED, 80 AND OVER; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77955468070     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.940619     Document Type: Article

References (31)

1. Tavazzi L, Volpi A. Remarks about postinfarction prognosis in light of the experience with the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) trials. Circulation. 1997;95:1341-1345.
2. Reitsma JB, Dalstra JA, Bonsel GJ, van der Meulen JH, Koster RW, Gunning-Schepers LJ, Tijssen JG. Cardiovascular disease in the Neth-erlands, 1975-1995: decline in mortality, but increasing numbers of patients with chronic conditions. Heart. 1999;82:52-56.
3. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mähönen M, Cepaitis Z, Kuulasmaa K, Keil U. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA project populations. Lancet. 2000;355:688-700.
4. Boersma E, Mercado N, Poldermans D, Gardien M, Vos J, Simoons ML. Acute myocardial infarction. Lancet. 2003;361:847-858.
5. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104:2158-2163.
6. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345:1473-1482.
7. Virmani R, Burke AP, Farb A. Sudden cardiac death. Cardiovasc Pathol. 2001;10:275-282.
8. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98: 2334-2351.
9. Bunch TJ, Hohnloser SH, Gersh BJ. Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators. Circulation. 2007;115:2451-2457.
10. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005;352:2581-2588.
11. Wilber DJ, Zareba W, Hall WJ, Brown MW, Lin AC, Andrews ML, Burke M, Moss AJ. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation. 2004;109:1082-1084.
12. Davis HT, DeCamilla J, Bayer LW. Survivorship patterns in the post hospital phase of myocardial infarction. Circulation. 1979;60:1252-1258.
13. Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984; 69:250-258.
14. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: structure, function, and time-dependence of risk. Circulation. 1992;85:I-2-I-10.
15. Mukharji J, Rude RE, Poole WK, Gustafson N, Thomas LJ Jr, Strauss HW, Jaffe AS, Muller JE, Roberts R, Raabe DS, Croft CH, Passamani E, Braunwald E, Willersion JT. Risk factors for sudden death after acute myocardial infarction: two year follow-up. Am J Cardiol. 1984;54:31-36.
16. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
17. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110:e82-e292.
18. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ. Prophylactic use of an implantable cardioverter- defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-2488.
19. Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D, Kornacewicz-Jach Z, Sredniawa B, Lupkovics G, Hofgärtner F, Lubinski A, Rosenqvist M, Habets A, Wegscheider K, Senges J; IRIS Investigators. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361:1427-1436.
20. Pratt CM, Greenway PS, Schoenfeld MH, Hibben ML, Reiffel JA. Exploration of the precision of classifying sudden cardiac death: implications for the interpretation of clinical trials. Circulation. 1996;93:519-524.
21. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm AJ, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJJ, Zipes DP. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 2001;22:1374-1450.
22. Thygesen K, Uretsky B. Acute ischemia as a trigger of sudden cardiac death. Eur Heart J. 2004;6:D88-D90.
23. Orn S, Cleland JG, Romo M, Kjekshus J, Dickstein K. Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction. Am J Med. 2005;118:752-758.
24. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003; 349:1893-1906.
25. Jargin S. Legal regulations of pathology in Russia. Int J Legal Med. 2008;122:535-536.
26. Uretsky BF, Thygesen K, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, Poole-Wilson PA, Ryden L. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial. Circulation. 2000;102:611-616.
27. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
28. Narang R, Cleland JGF, Erhardt L, Ball SG, Coats AJ, Cowley AJ, Dargie HJ, Hall AS, Hampton JR, Poole-Wilson PA. Mode of death in chronic heart failure: a request and proposition for more accurate classification. Eur Heart J. 1996;17:1390-1403.
29. Ørn S, Dickstein K. How do heart failure patients die? Eur Heart J 2002; 4: D59-D65.
30. Every N, Hallstrom A, McDonald KM, Parsons L, Thom D, Weaver D, Hlatky MA. Risk of sudden versus nonsudden cardiac death in patients with coronary artery disease. Am Heart J. 2002;144:390-396.
31. Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Mäkikallio TH, Juhani Airaksinen KE, Myerburg RJ. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol. 2003;42:652-658.